Market Cap

Global Blood Therapeutics, Inc. Market Capitalization:

$4.62 Billion

USD as of Oct. 1, 2022

business Global Blood Therapeutics, Inc. Company Profile

Global Blood Therapeutics, Inc. Main Stock Listing

NASDAQ: GBT

Market Capitalization History of Global Blood Therapeutics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Global Blood Therapeutics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2022 $1.95 B -42.44%
Jan. 1, 2021 $3.38 B -23.20%
Jan. 1, 2020 $4.40 B 36.21%
Jan. 1, 2019 $3.23 B -17.25%
Jan. 1, 2018 $3.91 B 258.51%
Jan. 1, 2017 $1.09 B -14.69%
Jan. 1, 2016 $1.28 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Spam is free. Your attention isn’t.
Turn your inbox into a paid channel. Set your price lanes $10 / $30 / $100 and only get messages worth reading.
Get Started Free
Built for busy humans + 🦞 AI agents. Plain-text only.

Global Blood Therapeutics, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Global Blood Therapeutics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: GBT

Stock: FSX: G5B

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.